Golden
NuMedii

NuMedii

Biotechnology company using Artificial Intelligence to discover drugs by translating life sciences big data into therapies

All edits

Edits on 20 Mar 2019
Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 20 Mar 2019 12:58 am
Edits made to:
Article (+18/-18 characters)

Article

AIDD also works to provide personalized therapeutic remedies to patients by analyzing complexities of disease manifestation at the molecular and clinical levels. The AIDD can identify subsets of patients that might react better to specific therapies. Understanding the complexities of drug and identifying specific subgroups of patients through artificial intelligence reduces the guesswork related to traditional medical therapies. The company used a systematic drug repositioningdrug repositioning bio-informatics approach on gene expression profiles to identify drugs to treat SCLC (Small Cell Lung Cancer).

Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 19 Mar 2019 10:45 pm
Edits made to:
Article (+22/-22 characters)

Article

Atul Butte, Gini Deshpande, and Joel Dudley founded NuMedii in 2008 and is headquartered in the San Francisco Bay AreaSan Francisco Bay Area.

Dawson Sewell
Dawson Sewell approved a suggestion from Golden's AI on 19 Mar 2019 10:41 pm
Edits made to:
Article (+8/-8 characters)

Article

NuMedii is a medical technology company using Artificial Intelligence and Big DataBig Data to accelerate the discovery of new drugs and therapies. With the available data on genomics, molecular and biomedical data, and knowledge of drugs, the company develops various machine learning models for finding new therapeutic drugs for cancer and other diseases. The company licenses its drug candidates with pharmaceuticals for development and commercialization. As of March 2019, the company primarily works in areas related to inflammation, oncology, and rare diseases.

Edits on 13 Mar 2019
Niroj Manandhar"initial article commit"
Niroj Manandhar edited on 13 Mar 2019 1:31 pm
Edits made to:
Infobox (+1 properties)
Timeline (+1 events) (+325 characters)
Description (+54/-27 characters)
Article (+2035 characters)
People (+6 cells) (+147/-8 characters)
Categories (+2 topics)
Related Topics (+2 topics)
Topic thumbnail

NuMedii

A pharmaceuticalBiotechnology company discoveringusing Artificial Intelligence to discover drugs by translating life sciences big data into therapies

Article

NuMedii is a medical technology company using Artificial Intelligence and Big Data to accelerate the discovery of new drugs and therapies. With the available data on genomics, molecular and biomedical data, and knowledge of drugs, the company develops various machine learning models for finding new therapeutic drugs for cancer and other diseases. The company licenses its drug candidates with pharmaceuticals for development and commercialization. As of March 2019, the company primarily works in areas related to inflammation, oncology, and rare diseases.

Product

The company’s Artificial Intelligence technology, AIDD (Artificial Intelligence for Drug Discovery) combines public medical information and combines it with proprietary data sources to curate and normalize data to find correlations and patterns to reveal new drugs, targets, and biomarkers. The AIDD machine learning models are said to use 5 billion facts and trillions of data point relationships between medicines and diseases.

Artificial Intelligence for Drug Discovery (AIDD)

AIDD also works to provide personalized therapeutic remedies to patients by analyzing complexities of disease manifestation at the molecular and clinical levels. The AIDD can identify subsets of patients that might react better to specific therapies. Understanding the complexities of drug and identifying specific subgroups of patients through artificial intelligence reduces the guesswork related to traditional medical therapies. The company used a systematic drug repositioning bio-informatics approach on gene expression profiles to identify drugs to treat SCLC (Small Cell Lung Cancer).

The company collaborates with other companies to research and discover new medicine for specific diseases. Numedii started collaborating with John Hopkins School of Medicine in November 2018, to discover therapeutic options and drug candidates for pancreatitis.

History

Atul Butte, Gini Deshpande, and Joel Dudley founded NuMedii in 2008 and is headquartered in the San Francisco Bay Area.

People

Name
Role
Related Golden topics

Asim Siddiqui

EmployeeChief Technology Officer



Gini Deshpande

Founder & Chief Executive Officer



Heather Arnett

Vice President Research



Linda De Young

Head, Product Development



Infobox

Categories

Related Topics

Timeline

November 1, 2018

NuMedii Announces Research Collaboration With Leading Academic Research Institution to Explore New Targets and Therapeutics for Pancreatitis

NuMedii, Inc.announced the formation of a research collaboration with Johns Hopkins School of Medicine with the goal of discovering new targets and therapeutic options for pancreatitis.

Edits on 15 Feb 2019
Rebecca Hammond
Rebecca Hammond approved a suggestion from Golden's AI on 15 Feb 2019 1:25 pm
Edits made to:
People (+4 cells) (+38 characters)

People

Name
Role
Related Golden topics

Asim Siddiqui

Employee



Atul Butte

Founder



Edits on 21 Jan 2019
Golden AI"Changed markets to industries"
Golden AI edited on 21 Jan 2019 10:16 pm
Edits on 10 Jan 2019
Golden AI
Golden AI edited on 10 Jan 2019 9:46 am
Edits made to:
Infobox (+1 properties)

Infobox

Edits on 12 Dec 2018
Golden AI"Import data"
Golden AI edited on 12 Dec 2018 1:06 am
Edits made to:
Infobox (+5 properties)
People (+2 cells) (+20 characters)
Categories (+1 topics)

People

Name
Role
Related Golden topics

Ted Driscoll

Investor



Infobox

Categories

Edits on 1 Sep 2018
Golden AI"Update description"
Golden AI edited on 1 Sep 2018 1:07 am
Edits made to:
Description (+95/-21 characters)
Topic thumbnail

NuMedii

Biotechnology company

A pharmaceutical company discovering drugs by translating life sciences big data into therapies

Edits on 19 Jul 2018
Golden AI"Update locations in infobox"
Golden AI edited on 19 Jul 2018 8:49 pm

Infobox

Edits on 16 Jul 2018
Golden AI"Update markets in infobox"
Golden AI edited on 16 Jul 2018 11:47 pm
Edits on 29 Jun 2018
Golden AI"Update infobox"
Golden AI edited on 29 Jun 2018 5:39 pm

Infobox

Edits on 29 May 2018
Golden AI"Initial topic creation"
Golden AI created this topic on 29 May 2018 9:40 pm
Edits made to:
Description (+21 characters)
People (+2 cells) (+21 characters)
Categories (+1 topics)
Topic thumbnail

 NuMedii

Biotechnology company

People

Name
Role
Related Golden topics

Gini Deshpande

Founder



Categories

No more activity to show.